[go: up one dir, main page]

GT200200075A - NEW ARILSULPHONAMIDS AS ANTIVIRAL AGENTS - Google Patents

NEW ARILSULPHONAMIDS AS ANTIVIRAL AGENTS

Info

Publication number
GT200200075A
GT200200075A GT200200075A GT200200075A GT200200075A GT 200200075 A GT200200075 A GT 200200075A GT 200200075 A GT200200075 A GT 200200075A GT 200200075 A GT200200075 A GT 200200075A GT 200200075 A GT200200075 A GT 200200075A
Authority
GT
Guatemala
Prior art keywords
hcmv
patients
new
arilsulphonamids
antiviral agents
Prior art date
Application number
GT200200075A
Other languages
Spanish (es)
Inventor
Tobias Wunberg
Wolfang Bender
Peter Eckenberg
Sabine Hallenberger
Kerstin Henninger
Jorg Keldenich
Armin Kern
Siegfried Raddatz
Jurgen Reefschlager
Gunter Schmidt
Holger Zimmermann
Franz Zumpe
Martin Radtke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200200075A publication Critical patent/GT200200075A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
    • C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
    • C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA PRESENTE INVENCION SE REFIERE A NUEVAS ARILSULFONAMIDAS DE FORMULA GENERAL (I) EN DONDE X,A,R1,R2,R3,R4, SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE. ESTOS COMPUESTOS MUESTRAN UNA ACTIVIDAD ANTIVIRAL FRENTE A REPRESENTANTES DEL GRUPO DE HERPES VIRIDAE, ESPECIALMENTE FRENTE AL CITOMEGALOVIRUS HUMANO (HCMV) POR LO QUE SON UTILES EN LA PREVENCION Y ESTADOS INFECCIOSOS CAUSADOS POR HCMV EN PACIENTES CON SIDA, EN PACIENTES DE TRANSPLANTE DE MEDULA OSEA Y ORGANOS, EN RECIEN NACIDOS Y NIÑOS PEQUEÑOS, EN PACIENTES INMUNOSUPRIMIDOS POR CANCER, EN EMBARAZADAS POR INFECCION AGUDA CAUSADA POR HCMV.THE PRESENT INVENTION REFERS TO NEW ARILSULFONAMIDS OF GENERAL FORMULA (I) WHERE X, A, R1, R2, R3, R4, ARE FUNCTIONAL GROUPS DESCRIBED IN THE RECORD. THESE COMPOUNDS SHOW AN ANTIVIRAL ACTIVITY AGAINST REPRESENTATIVES OF THE HERPES VIRIDAE GROUP, ESPECIALLY AGAINST THE HUMAN CITOMEGALOVIRUS (HCMV), SO THAT THEY ARE USEFUL IN THE PREVENTION AND INFECTIVE STATES CAUSED BY HCMV IN PATIENTS WITH AIDS, IN PATIENTS ORGANS, IN NEWLY BORN AND SMALL CHILDREN, IN IMMUNE SUPPRESSED PATIENTS BY CANCER, IN PREGNANT BY ACUTE INFECTION CAUSED BY HCMV.

GT200200075A 2001-04-19 2002-04-18 NEW ARILSULPHONAMIDS AS ANTIVIRAL AGENTS GT200200075A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10119137 2001-04-19

Publications (1)

Publication Number Publication Date
GT200200075A true GT200200075A (en) 2002-12-24

Family

ID=7681939

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200200075A GT200200075A (en) 2001-04-19 2002-04-18 NEW ARILSULPHONAMIDS AS ANTIVIRAL AGENTS

Country Status (9)

Country Link
KR (1) KR20030088509A (en)
AR (1) AR034309A1 (en)
CO (1) CO5540388A2 (en)
DE (1) DE10148598A1 (en)
EC (1) ECSP034813A (en)
GT (1) GT200200075A (en)
PE (1) PE20021061A1 (en)
SV (1) SV2003000995A (en)
ZA (1) ZA200307892B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7482366B2 (en) * 2001-12-21 2009-01-27 X-Ceptor Therapeutics, Inc. Modulators of LXR
KR20050033653A (en) * 2002-08-23 2005-04-12 리겔 파마슈티칼스, 인크. Pyridyl substituted heterocycles useful for treating or preventing hcv infection
EP1581213A4 (en) * 2002-12-18 2008-11-19 Cytovia Inc 3,5-DISUBSTITUES-1,2,4-OXADIAZOLES AND ANALOGS AS ACTIVATORS OF CASPASES AND APOPTOSIS PROMOTERS, AND USE THEREOF
DE10300109A1 (en) * 2003-01-07 2004-07-15 Bayer Healthcare Ag Method for inhibiting replication of herpes viruses
WO2004099165A2 (en) 2003-05-02 2004-11-18 Rigel Pharmaceuticals, Inc. Heterocyclic compounds and hydro isomers thereof
US8580842B2 (en) 2003-09-30 2013-11-12 Abbott Gmbh & Co. Kg Heteroaryl-substituted 1,3-dihydroindol-2-one derivatives and medicaments containing them
US7410979B2 (en) 2003-11-19 2008-08-12 Rigel Pharmaceuticals, Inc. Synergistically effective combinations of dihaloacetamide compounds and interferon or ribavirin against HCV infections
US7514434B2 (en) 2004-02-23 2009-04-07 Rigel Pharmaceuticals, Inc. Heterocyclic compounds having an oxadiazole moiety and hydro isomers thereof
JP2008540425A (en) 2005-05-02 2008-11-20 ライジェル ファーマシューティカルズ， インコーポレイテッド Heterocyclic antiviral compounds containing metabolizable moieties and uses thereof
US8486979B2 (en) 2006-12-12 2013-07-16 Abbvie Inc. 1,2,4 oxadiazole compounds and methods of use thereof
UY30846A1 (en) 2006-12-30 2008-07-31 Abbott Gmbh & Amp OXINDOL DERIVATIVES REPLACED, MEDICINES THAT UNDERSTAND AND USE THEMSELVES
US20080255203A1 (en) * 2007-04-12 2008-10-16 Abbott Laboratories Heterocyclic compounds and their methods of use
US8703774B2 (en) 2007-12-07 2014-04-22 AbbVie Deutschland GmbH & Co. KG Carbamate-substituted oxindole derivatives and use thereof for the treatment of vasopressin-dependent diseases
US8546401B2 (en) 2007-12-07 2013-10-01 AbbVie Deutschland GmbH & Co. KG 5,6-disubstituted oxindole-derivatives and use thereof for treating vasopressin-dependent diseases
JP5595926B2 (en) 2007-12-07 2014-09-24 アボット ゲーエムベーハー ウント カンパニー カーゲー 5-Halogen-substituted oxindole derivatives and their use in the treatment of vasopressin-dependent diseases
CA2707667C (en) 2007-12-07 2016-02-23 Abbott Gmbh & Co. Kg Amidomethyl-substituted oxindole derivatives and the use thereof for the treatment of vasopressin-dependent illnesses
EP2435080A2 (en) 2009-05-29 2012-04-04 Abbott Laboratories Pharmaceutical compositions for the treatment of pain

Also Published As

Publication number Publication date
DE10148598A1 (en) 2002-10-24
SV2003000995A (en) 2003-03-18
KR20030088509A (en) 2003-11-19
ZA200307892B (en) 2004-10-11
PE20021061A1 (en) 2002-12-12
CO5540388A2 (en) 2005-07-29
ECSP034813A (en) 2003-12-01
AR034309A1 (en) 2004-02-18

Similar Documents

Publication Publication Date Title
GT200200075A (en) NEW ARILSULPHONAMIDS AS ANTIVIRAL AGENTS
GT200200053A (en) NEW SPIROCICLIC DERIVATIVES AND THEIR USE AS INHIBITORS OF PHOSPHODIESTERASA-7
BR0214999A (en) Amide-substituted imidazopyridines
ECSP093601A (en) PROTEINS DERIVED FROM THE WHITE SPOT SYNDROME VIRUS AND ITS USES
GT200100213A (en) SPIROPIRIMIDIN-2,4,6-TRIONA METALOPROTEINASE INHIBITORS.
BRPI0411900A (en) antiviral compounds and methods
MX9403380A (en) HIV PROTEASE INHIBITORS USEFUL FOR THE TREATMENT OF AIDS.
ATE249219T1 (en) ANTIVIRAL COMPOUNDS
HN2003000348A (en) BENZOFURAN COMPOUNDS, COMPOSITIONS AND METHODS FOR TREATMENT AND VIRAL INFECTION OF HEPATITIS C AND ASSOCIATED ILLNESSES.
CY1107200T1 (en) SUSPITUS SUSPENSION UNITS C
EA200500584A1 (en) NUCLEOSIDE DERIVATIVES FOR THE TREATMENT OF INFECTIOUS DISEASES CAUSED BY THE HEPATITIS C VIRUS
SG161315A1 (en) Compounds and methods for the treatment or prevention of flavivirus infections
TNSN06123A1 (en) C-class oligonucleotide analogs with enhaced immunostimulatory potency
ATE319460T1 (en) ONCOLYTIC VESICULAR STOMATITIS VIRUS
PE20030857A1 (en) COMPOUNDS AS INHIBITORS OF THE PROTEASE SERINE NS3 OF THE HEPATITIS C VIRUS
GT200300269A (en) NEW AROMATIC FLUOROGLUCOSID DERIVATIVES, MEDICINES CONTAINING THESE COMPOUNDS AND THEIR USES
ATE373005T1 (en) THIENOPYRROLES AS ANTIVIRAL AGENTS
GB0110832D0 (en) Antiviral compounds
PA8573401A1 (en) INHIBITORS OF THE RNA-DEPENDENT RNA POLYMERASE OF THE HEPATITIS C VIRUS AND COMPOSITIONS AND TREATMENTS USING THEM
ES2165269A1 (en) Alpha-ketoamide derivatives
AR037883A1 (en) BENZOFURANS 2-PHENYL SUBSTITUTED AS STROGEN AGENTS
TW200633995A (en) Andrographolide derivatives to treat viral infections
AU2003287259A1 (en) The use of endoperoxides for the treatment of infections caused by flaviviridae, including hepatitis c, bovine viral diarrhea and classical swine fever virus
EA200400214A1 (en) AZITROMYCIN IN THE FORM OF SINGLE DOSE
ES2061770T3 (en) ANTIBIOTICS TAN-1057.